Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Role of Patient-Reported Outcome Measures in the Assessment of Central Nervous System Agents
Ari Gnanasakthy, Carla DeMuro, Marci Clark, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 10, 2021
Use of Patient and Investigator Global Impression Scales: A Review of Food and Drug Administration-Approved Labeling, 2009 to 2019
Ari Gnanasakthy, Amy Barrett, Lindsey Norcross, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
October 31, 2018
A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression
Ellen Snyder, Bing Cai, Carla DeMuro, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 4, 2019
A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)
Ari Gnanasakthy, Amy Barrett, Emily Evans, et al.
Muscle & Nerve
|
February 14, 2016
Development of the sporadic inclusion body myositis physical functioning assessment
Carla DeMuro, Sandy Lewis, Linda Lowes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014)
Ari Gnanasakthy, Carla DeMuro, Marci Clark, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 13, 2011
Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
Josephine M Norquist, Cynthia Girman, Sheri Fehnel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 12, 2013
Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010)
Carla DeMuro, Marci Clark, Lynda Doward, et al.
Value in Health Regional Issues
|
April 27, 2018
Patient-Reported Outcomes in Latin America: Implementation in Research and Role in Emerging HTA Systems
Randall Winnette, Victor Zárate, Gerardo Machnicki, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 16, 2012
Reasons for rejection of patient-reported outcome label claims: a compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006-2010
Carla DeMuro, Marci Clark, Margaret Mordin, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Role of Patient-Reported Outcome Measures in the Assessment of Central Nervous System Agents
Ari Gnanasakthy, Carla DeMuro, Marci Clark, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 10, 2021
Use of Patient and Investigator Global Impression Scales: A Review of Food and Drug Administration-Approved Labeling, 2009 to 2019
Ari Gnanasakthy, Amy Barrett, Lindsey Norcross, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
October 31, 2018
A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression
Ellen Snyder, Bing Cai, Carla DeMuro, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 4, 2019
A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)
Ari Gnanasakthy, Amy Barrett, Emily Evans, et al.
Muscle & Nerve
|
February 14, 2016
Development of the sporadic inclusion body myositis physical functioning assessment
Carla DeMuro, Sandy Lewis, Linda Lowes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014)
Ari Gnanasakthy, Carla DeMuro, Marci Clark, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 13, 2011
Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
Josephine M Norquist, Cynthia Girman, Sheri Fehnel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 12, 2013
Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010)
Carla DeMuro, Marci Clark, Lynda Doward, et al.
Value in Health Regional Issues
|
April 27, 2018
Patient-Reported Outcomes in Latin America: Implementation in Research and Role in Emerging HTA Systems
Randall Winnette, Victor Zárate, Gerardo Machnicki, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 16, 2012
Reasons for rejection of patient-reported outcome label claims: a compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006-2010
Carla DeMuro, Marci Clark, Margaret Mordin, et al.
Page
of 5